Biotech acquisition
This article was originally published in The Tan Sheet
Executive Summary
The Netherlands-based DSM Food Specialties, which develops ingredients for the food and beverage industries, strengthens its global position in food enzymes with the acquisition of U.S. biotechnology company Valley Research. Terms of the deal were not disclosed, but the acquisition has been finalized, DSM announces July 11. While strengthening its product portfolio, the deal also allows DSM to "offer regional blending and solution-providing platforms to customers," according to the firm. DSM provides enzymes and other ingredients and to food and beverage firms worldwide...
You may also be interested in...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.